Comments
Jubilant Life Sciences has received approval from the US health regulator to market generic Sporanox capsules, used for treating fungal infections, in the American market.
The company has received approval from the US Food and Drug Administration (USFDA) for Itraconazole capsules, a generic version of Janssen Pharmaceuticals’ Sporanox, Jubilant Life Sciences said in a regulatory filing today.
As on December 31, 2016 Jubilant had 73 abbreviated new drug applications (ANDAs) for oral solids filed in the US, of which 49 have been approved.
Shares of the company were trading 1.8 per cent up at Rs 720.30 apiece on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.